BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1706603)

  • 1. Pathophysiological role of augmented atrial natriuretic polypeptide gene expression in DOCA-salt hypertension. Effects of atrial natriuretic polypeptide monoclonal antibody.
    Itoh H; Nakao K; Mukoyama M; Arai H; Yamada T; Saito Y; Shiono S; Hosoda K; Shirakami G; Suga S
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):39-44. PubMed ID: 1706603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
    Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
    J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The changes in natriuretic peptide receptors (NP-R) in the lung and kidney in DOCA-salt hypertensive rats].
    Liu LM; Yoshimi T
    Nihon Naibunpi Gakkai Zasshi; 1995 May; 71(4):587-96. PubMed ID: 7796923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phasic plasma atrial natriuretic polypeptide changes in DOCA-salt hypertensive rats.
    Sato Y; Ito Y; Ando K; Ogata E; Fujita T
    Jpn Heart J; 1990 Sep; 31(5):703-11. PubMed ID: 2148777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
    Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma brain natriuretic peptide levels in DOCA-salt hypertensive rats: relation to blood pressure and cardiac concentration.
    Yokota N; Aburaya M; Yamamoto Y; Kato J; Kitamura K; Kida O; Eto T; Minamino N; Kangawa K; Matsuo H
    Biochem Biophys Res Commun; 1990 Dec; 173(2):632-8. PubMed ID: 2148083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats.
    Nuglozeh E; Gauquelin G; Garcia R; Tremblay J; Schiffrin EL
    Am J Physiol; 1990 Jul; 259(1 Pt 2):F130-7. PubMed ID: 2165357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased density of vascular receptors for atrial natriuretic peptide in DOCA-salt hypertensive rats.
    Schiffrin EL; St-Louis J
    Hypertension; 1987 May; 9(5):504-12. PubMed ID: 3032791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles in experimental malignant hypertension.
    Kohno M; Horio T; Yoshiyama M; Takeda T
    Hypertension; 1992 Feb; 19(2):206-11. PubMed ID: 1531333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of adrenal cortical and medullary atrial natriuretic peptide and gene expression in rats with deoxycorticosterone acetate-salt treatment.
    Lai FJ; Shin SJ; Lee YJ; Lin SR; Jou WY; Tsai JH
    Endocrinology; 2000 Jan; 141(1):325-32. PubMed ID: 10614654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective ANF-R2/ANP-C receptor-mediated signalling in hypertension.
    Marcil J; Anand-Srivastava MB
    Mol Cell Biochem; 1995; 149-150():223-31. PubMed ID: 8569733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF; Jin HK; Paul R; Nagahama S
    J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented expression of atrial natriuretic polypeptide gene in ventricles of spontaneously hypertensive rats (SHR) and SHR-stroke prone.
    Arai H; Nakao K; Saito Y; Morii N; Sugawara A; Yamada T; Itoh H; Shiono S; Mukoyama M; Ohkubo H
    Circ Res; 1988 May; 62(5):926-30. PubMed ID: 2966015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased renal atrial natriuretic peptide synthesis in rats with deoxycorticosterone acetate-salt treatment.
    Lee YJ; Shin SJ; Tan MS; Hsieh TJ; Tsai JH
    Am J Physiol; 1996 Oct; 271(4 Pt 2):F779-89. PubMed ID: 8898007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
    Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
    J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma atrial natriuretic peptide in DOCA-NaCl-treated rats.
    Tikkanen T; Tikkanen I; Fyhrquist F
    Acta Physiol Scand; 1987 Feb; 129(2):151-5. PubMed ID: 2953170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of cardiac hypertrophy, myosin heavy chain isoform expression, and natriuretic peptide production in DOCA-salt rats.
    Yokota N; Bruneau BG; Fernandez BE; de Bold ML; Piazza LA; Eid H; de Bold AJ
    Am J Hypertens; 1995 Mar; 8(3):301-10. PubMed ID: 7540847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous measurement of atrial natriuretic polypeptide (ANP) messenger RNA and ANP in rat heart--evidence for a preferentially increased synthesis and secretion of ANP in left atrium of spontaneously hypertensive rats (SHR).
    Arai H; Nakao K; Saito Y; Morii N; Sugawara A; Yamada T; Itoh H; Shiono S; Mukoyama M; Ohkubo H
    Biochem Biophys Res Commun; 1987 Oct; 148(1):239-45. PubMed ID: 2960324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure and renal responses to synthetic rat atrial natriuretic factor in deoxycorticosterone acetate-salt hypertension.
    Kohzuki M; Abe K; Yasujima M; Kasai Y; Hiwatari M; Kanazawa M; Sato M; Omata K; Kudo K; Takeuchi K
    Tohoku J Exp Med; 1989 Apr; 157(4):301-11. PubMed ID: 2525826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.